To argue that HIV testing should be offered when patients first present with suspected herpes zoster ophthalmicus (HZO) or varicella zoster virus (VZV) keratitis, and to describe a practical approach for eye clinics.
Approach:
Rationale: The article describes herpes zoster as an HIV indicator condition and notes that national guidance recommends offering HIV testing when an indicator condition is identified.
Proposed clinic practice: Offer HIV testing at the initial appointment to every patient with suspected HZO or VZV keratitis, regardless of age. A VZV swab request should prompt the offer before results are available.
Key Findings:
The article reports that ophthalmologists often lead initial HZO care, while management commonly focuses on antiviral treatment and ocular follow-up rather than systemic testing.
It cites a historical series of 112 patients with HZO in which 26% were HIV-positive; all HIV-positive patients were younger than 50.
The article states that age should not determine whether testing is offered, noting that older adults account for an increasing proportion of new and late HIV diagnoses.
The authors report that UK ophthalmology lacks specific guidance or a standardised pathway for HIV testing in HZO or VZV keratitis.
Interpretation:
The authors argue that offering HIV testing when HZO or VZV keratitis is first suspected, rather than waiting for a positive VZV swab, may help identify people who would otherwise be missed.
Limitations:
The article presents a clinical recommendation and practical approach; it does not evaluate the effectiveness or outcomes of routine testing.
The authors report that a clinical governance review identified a gap in ophthalmology practice, but do not provide the review’s methods or results.
Conclusion:
The authors recommend offering HIV testing to all patients with suspected HZO or VZV keratitis at presentation, with a VZV swab request serving as a prompt.
Higher medical expenses increased financial anxiety and reduced willingness to schedule recommended procedures in 3 studies, with stronger effects among financially stressed participants.